Physician profile
Ryan T Mcbee
NPI 1326247552
$3,911.80
in general payments reported to CMS, 2019-2025
20 companies · $420 in 2025
The $420 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2020: $324 · 2021: $343 · 2022: $614 · 2023: $300 · 2024: $1,662 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,498 · Travel and Lodging: $885.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,497.57 |
| Travel and Lodging | $884.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,682.44 | 2022-2025 | Infuse, Xiidra, Miebo |
| Novartis Pharmaceuticals Corporation | $644.48 | 2019-2023 | |
| Sun Pharmaceutical Industries INC. | $354.36 | 2019-2025 | Cequa |
| Alcon Vision LLC | $342.51 | 2019-2025 | Precision7, Rocklatan |
| Biotissue Holdings INC. | $106.11 | 2024-2025 | |
| Horizon Therapeutics Plc | $103.71 | 2022-2023 | Tepezza |
| Aerie Pharmaceuticals, INC. | $84.59 | 2019-2021 | |
| Oyster Point Pharma, INC. | $77.95 | 2023-2024 | Tyrvaya |
| Abbvie INC. | $75.98 | 2022-2025 | |
| Lkc Technologies, INC. | $71.99 | 2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $58.20 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $55.80 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $55.50 | 2025 | Xdemvy |
| Harrow Eye, LLC | $53.20 | 2023-2024 | Vevye |
| Regeneron Healthcare Solutions, INC. | $41.67 | 2020-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $27.46 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Amgen INC. | $24.09 | 2025 | Tepezza |
| Thea Pharma INC. | $19.31 | 2025 | Iyuzeh |
| Glaukos Corporation | $17.52 | 2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Alcon Research LLC | $14.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Mcbee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.